Integration of metabolism and inflammation by lipid-activated nuclear receptors
View abstract on PubMed
Summary
This summary is machine-generated.Peroxisome proliferator-activated receptors (PPARs) and liver X receptors (LXRs) are key regulators of lipid metabolism and inflammation. Targeting these nuclear receptors offers potential for treating metabolic diseases and modulating immune responses.
Area Of Science
- Molecular biology
- Endocrinology
- Immunology
Background
- Nuclear receptors Peroxisome proliferator-activated receptors (PPARs) and Liver X receptors (LXRs) are crucial regulators of lipid metabolism and inflammation.
- PPARs are activated by fatty acids, while LXRs are activated by cholesterol metabolites.
- Both receptor types influence the expression of genes involved in metabolic and inflammatory pathways.
Purpose Of The Study
- To highlight the role of PPARs and LXRs in integrating metabolic and inflammatory signals.
- To explore their potential as therapeutic targets for metabolic diseases and inflammatory conditions.
Main Methods
- Review of existing literature on PPAR and LXR signaling pathways.
- Analysis of gene expression data related to lipid metabolism and inflammation.
- Examination of the role of these receptors in disease models.
Main Results
- PPARs and LXRs act as key integrators of metabolic and inflammatory cues.
- These nuclear receptors control a wide array of genes impacting lipid homeostasis and immune function.
- Dysregulation of PPAR and LXR signaling is implicated in diseases like atherosclerosis and type 2 diabetes.
Conclusions
- PPARs and LXRs represent promising therapeutic targets for metabolic diseases.
- Modulating PPAR and LXR activity can be a strategy for managing inflammation and immune responses.